Evidence map›Paper›PMID 37577673›Full record

ArticlebioRxiv : the preprint server for biology2024

Modeling Allosteric Mechanisms of Eukaryotic Type II Topoisomerases.

Stefania Evoli, Nilusha L Kariyawasam, Karin C Nitiss, John L Nitiss, Jeff Wereszczynski

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stefania EvoliDepartment of Physics, Illinois Institute of Technology, Chicago, USA.ORCID 0000-0003-1242-1550
Nilusha L KariyawasamDepartment of Physics, Illinois Institute of Technology, Chicago, USA.ORCID 0000-0001-5727-1205
Karin C NitissPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL.ORCID 0000-0002-3548-5090
John L NitissPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL.ORCID 0000-0002-1013-4972
Jeff WereszczynskiDepartment of Physics, Illinois Institute of Technology, Chicago, USA.ORCID 0000-0002-2218-3827
Illinois Institute of Technology · USUniversity of Illinois Chicago · US

Funding

Probing the Structure/Function/Dynamics Relationship in Biomolecular Complexes With Multiscale Computational TechniquesR35GM119647 · NIGMS · ILLINOIS INSTITUTE OF TECHNOLOGY · PI WERESZCZYNSKI, JEFFERY · 2016 to 2025
$3.8M
NIGMS NIH HHS R35 GM119647
6 · The paper itself

Abstract

Type II topoisomerases (TopoIIs) are ubiquitous enzymes that are involved in crucial nuclear processes such as genome organization, chromosome segregation, and other DNA metabolic processes. These enzymes function as large, homodimeric complexes that undergo a complex cycle of binding and hydrolysis of two ATP molecules in their ATPase domains, which regulates the capture and passage of one DNA double-helix through a second, cleaved DNA molecule. This process requires the transmission of information about the state of the bound nucleotide over vast ranges in the TopoII complex. How this information is transmitted at the molecular level to regulate TopoII functions and how protein substitutions disrupt these mechanisms remains largely unknown. Here, we employed extensive microsecond scale molecular dynamics simulations of the yeast TopoII enzyme in multiple nucleotide-bound states and with amino acid substitutions near both the N- and C-terminals of the complex. Simulation results indicate that the ATPase domains are remarkably flexible on the sub-microsecond timescale and that these dynamics are modulated by the identity of the bound nucleotides and both local and distant amino acid substitutions. Network analyses point towards specific allosteric networks that transmit information about the hydrolysis cycle throughout the complex, which include residues in both the protein and the bound DNA molecule. Amino acid substitutions weaken many of these pathways. Together, our results provide molecular-level details on how the TopoII catalytic cycle is controlled through nucleotide binding and hydrolysis and how mutations may disrupt this process.

Identifiers

PMID37577673
PMCPMC10418245
OpenAlexW4385516433

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.